Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million

What: Enliven Therapeutics' Chief Medical Officer sold **40,000** shares for approximately **$1.2 million**.
Why: The sale may indicate a change in the officer's confidence in the company's future performance.
Signal: This transaction could be a bearish signal for Enliven Therapeutics' stock price.
Target: The company's stock price may be at risk of falling below its current level.
Risk: Investors may face a higher risk of losses if they hold Enliven Therapeutics' stock.